查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1634163

全球眼科縫合線市場 - 2025 - 2033

Global Ophthalmic Sutures Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球眼科縫合線市場達到4.637億美元，預計2033年將達到8.715億美元，2025-2033年預測期間複合年成長率為7.3%。

眼科縫合線是專門的醫用線或線，用於閉合眼睛或周圍眼組織的手術切口或傷口。這些縫線旨在提供精確的組織近似，支持癒合，並最大限度地減少對脆弱眼部結構的創傷。它們在眼科手術中至關重要，包括角膜、鞏膜、虹膜、眼瞼和眼眶組織的手術。眼科縫合線非常薄且精緻，以匹配眼組織敏感和複雜的性質。

在眼部疾病盛行率增加和手術技術進步等因素的推動下，眼科縫合線市場持續成長。例如，2024 年10 月，全球領先的醫療技術公司Corza Medical 致力於提供卓越的服務、值得信賴的性能和卓越的價值，推出了其創新的新系列Onatec 眼科顯微手術縫合線，並在2020 年的美國眼科學會(AAO) 會議上亮相。

市場動態：

驅動程式和限制

眼部疾病盛行率上升

眼部疾病盛行率的上升極大地推動了眼科縫合線市場的成長，預計將在預測期內推動市場的成長。白內障是全世界最常見的眼部疾病之一，尤其是在老年族群。隨著年齡的成長，患白內障的可能性也會增加。白內障手術是全世界最常見的手術之一。

例如，根據 WK 眼科研究所的數據，全世界每年約進行 2,800 萬例白內障手術，其中近 15% 發生在美國。白內障手術數量預計將進一步增加，從而增加對眼科縫合線的需求。

糖尿病視網膜病變是一種影響視網膜的糖尿病併發症，越來越受到人們的關注。國際糖尿病聯盟 (IDF) 報告稱，全球約有 4.63 億糖尿病患者，其中高達 28% 面臨糖尿病視網膜病變的風險。晚期糖尿病視網膜病變的治療通常涉及玻璃體切除術（去除眼睛中的玻璃體凝膠），這需要專門的縫合線來修復和閉合手術期間形成的切口。

老年黃斑部病變（AMD）是另一種隨著年齡成長而變得越來越常見的眼部疾病。據美國眼科學會稱，到 2040 年，預計將有 2.88 億人患有 AMD。雖然 AMD 通常需要注射等藥物治療，但晚期病例可能需要手術干預，例如視網膜手術，其中眼科縫合對於組織修復和閉合至關重要。

轉向無縫線手術技術

向無縫線手術技術的轉變預計將阻礙眼科縫合線市場的成長。雖然眼科縫合線對於許多眼科手術至關重要，但無縫線技術的開發和採用正在減少各種外科手術中對傳統縫合線的依賴。例如，在白內障手術中，採用飛秒雷射技術減少了縫合的需要。這項技術使外科醫生能夠進行精確的角膜切口，通常不需要縫合來閉合。

外科醫生擴大在白內障和屈光手術中使用自封閉角膜切口。這些切口自然閉合，無需縫合，完全減少了縫合的需要。這種趨勢在屈光手術（例如 LASIK、PRK）中尤其明顯，其中切口小而精確，通常無需縫合，從而實現更快的恢復時間和最小化疤痕。

在許多眼科手術中，組織黏合劑或氰基丙烯酸酯膠作為縫合線的替代品越來越受歡迎，特別是在角膜傷口修復和視網膜手術等手術中。這些黏合劑為某些類型的眼部手術提供了更快、更有效的閉合，與傳統縫線相比具有多種優勢，例如易於使用、縮短手術時間和減少併發症。例如，在視網膜剝離手術中，有時會使用氰基丙烯酸酯組織黏合劑來密封視網膜撕裂，從而無需縫合。

有關此報告的更多詳細資訊 - 索取樣本

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的片段
  • 按吸收能力摘錄
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 眼部疾病盛行率上升
    • 限制
      • 轉向無縫線手術技術
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：眼科縫合線市場（按類型）

  • 天然縫線
  • 合成縫線

第 6 章：眼科縫合線市場（依吸收能力）

  • 可吸收縫線
  • 不可吸收縫線

第 7 章：眼科縫合線市場（按應用）

  • 白內障手術
  • 角膜移植手術
  • 玻璃體切除手術
  • 虹膜切除手術
  • 眼部整形手術
  • 其他

第 8 章：眼科縫合線市場（依最終用戶）

  • 醫院
  • 眼科診所
  • 門診手術中心
  • 其他

第 9 章：眼科縫合線市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 11 章：公司簡介

  • B. Braun SE
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Johnson & Johnson Medical NV.
  • Medtronic plc
  • DemeTECH Corporation
  • Corza Medical
  • KATSAN Katgut Industry and Trade Inc.
  • Golnit
  • Accutome Inc.
  • Aurolab
  • Dolphin Sutures

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD8962

The global ophthalmic sutures market reached US$ 463.7 million in 2024 and is expected to reach US$ 871.5 million by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033.

Ophthalmic sutures are specialized medical threads or strands used to close surgical incisions or wounds in the eye or surrounding ocular tissues. These sutures are designed to provide precise tissue approximation, support healing, and minimize trauma to delicate ocular structures. They are crucial in ophthalmic surgeries, including procedures on the cornea, sclera, iris, eyelids, and orbital tissues. Ophthalmic sutures are extremely thin and delicate to match the sensitive and intricate nature of eye tissues.

The ophthalmic sutures market experiencing consistent growth, driven by factors such as the increasing prevalence of eye disorders and advancements in surgical techniques. For instance, in October 2024, Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, launched its innovative new line of Onatec ophthalmic microsurgical sutures, unveiled at the American Academy of Ophthalmology (AAO) conference in Chicago.

Market Dynamics: Drivers & Restraints

Rising prevalence of eye disorders

The rising prevalence of eye disorders is significantly driving the growth of the ophthalmic sutures market and is expected to drive the market over the forecast period. Cataracts are one of the most common eye conditions worldwide, particularly in the aging population. As people age, the likelihood of developing cataracts increases. Cataract surgery is one of the most common procedures performed worldwide.

For instance, according to the WK Eye Institute, there are roughly 28 million cataract surgeries performed worldwide each year, with nearly 15 percent occurring in the United States. The number of cataract surgeries is projected to rise further, consequently increasing the demand for ophthalmic sutures.

Diabetic retinopathy, a complication of diabetes that affects the retina, is a growing concern. The International Diabetes Federation (IDF) reports that there are approximately 463 million people with diabetes worldwide, and up to 28% of them are at risk for diabetic retinopathy. Treatment for advanced stages of diabetic retinopathy often involves vitrectomy (removal of the vitreous gel from the eye), which requires specialized sutures to repair and close incisions made during surgery.

Age-related macular degeneration (AMD) is another eye disorder that is becoming more common with aging. By 2040, 288 million people are expected to suffer from AMD, according to the American Academy of Ophthalmology. While AMD typically requires medical treatments like injections, advanced cases may need surgical interventions, such as retinal surgeries, where ophthalmic sutures are essential for tissue repair and closure.

Shift towards sutureless surgical techniques

Shift towards sutureless surgical techniques is expected to hamper the growth of the ophthalmic sutures market. While ophthalmic sutures are essential for many eye surgeries, the development and adoption of sutureless techniques are reducing the dependency on traditional sutures in various surgical procedures. For instance, in cataract surgeries, adopting femtosecond laser technology has reduced the need for sutures. This technology enables surgeons to perform precise corneal incisions that often do not require sutures for closure.

Surgeons are increasingly utilizing self-sealing corneal incisions in cataract and refractive surgeries. These incisions naturally close without requiring sutures, reducing the need for suturing altogether. This trend is particularly evident in refractive surgeries (e.g., LASIK, PRK) where small, precise incisions are made, often without sutures, leading to faster recovery times and minimal scarring.

Tissue adhesives or cyanoacrylate-based glues are gaining popularity as alternatives to sutures in many ophthalmic surgeries, especially for procedures like corneal wound repair and retinal surgeries. These adhesives provide a quicker and more efficient closure for certain types of eye surgeries, offering several advantages over traditional sutures, such as ease of application, reduced surgical time, and fewer complications. For instance, in retinal detachment surgeries, cyanoacrylate tissue adhesives are sometimes used to seal retinal tears, eliminating the need for sutures.

For more details on this report - Request for Sample

Segment Analysis

The global ophthalmic sutures market is segmented based on type, absorption capacity, application, end-user and region.

Absorption Capacity:

The non-absorbable sutures segment is expected to dominate the ophthalmic sutures market share

Non-absorbable sutures are preferred in surgeries where long-term tissue support is crucial, such as scleral or corneal repairs, retinal surgeries, and glaucoma surgeries. These surgeries often involve tissues that take a longer time to heal or need sustained support. For instance, in glaucoma surgeries like trabeculectomy, non-absorbable sutures are used to ensure that the incision remains closed until the wound fully heals. Their ability to provide durable support is essential for reducing the risk of postoperative complications like wound dehiscence (wound opening).

Nylon and polypropylene, the two most common materials used for non-absorbable sutures, offer superior tensile strength and durability compared to absorbable sutures. This makes them ideal for use in areas that experience high mechanical stress or require precise closure. For instance, in corneal surgeries, such as penetrating keratoplasty (corneal transplants), where precise wound closure is critical to prevent infection and ensure proper healing, non-absorbable sutures ensure that the incision site is securely closed for a prolonged period.

Non-absorbable sutures do not dissolve over time, which makes them suitable for applications where the removal of sutures is not necessary. For instance, in cataract surgeries, retinal procedures, or glaucoma surgeries, non-absorbable sutures can remain in place indefinitely without causing issues, reducing the need for follow-up procedures. In cases like eyelid surgeries, the sutures may remain permanently in place, providing lasting structural support to the eyelids.

Geographical Analysis

North America is expected to hold a significant position in the ophthalmic sutures market share

Ophthalmic diseases such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and other vision-related disorders are more prevalent in North America especially in the United States and Canada, particularly due to an aging population and increasing lifestyle-related factors like diabetes. For instance, according to the American Academy of Ophthalmology (AAO), by 2050, the number of people in the U.S. with diabetic retinopathy is expected to rise to 14.6 million, driving an increased need for surgeries that require ophthalmic sutures.

The ophthalmic sutures market in North America benefits from a well-established healthcare market, with high adoption rates of ophthalmic procedures. In particular, cataract surgeries in the U.S. are expected to increase due to the country's aging population and advancements in surgical techniques.

For instance, the National Eye Institute (NEI) projects that cataract surgery in the U.S. alone will rise sharply in the coming decades, from approximately 3.6 million in 2020 to 5.7 million by 2050. Cataract surgeries often require sutures to close the incision, and as the number of surgeries increases, so does the demand for ophthalmic sutures.

Asia-Pacific is growing at the fastest pace in the ophthalmic sutures market

The Asia-Pacific region has a large and growing population that is increasingly affected by a range of eye disorders. Conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and corneal diseases are becoming more prevalent due to an aging population, lifestyle changes, and rising diabetes rates. For instance, Cataracts are a major concern in Asia. The World Health Organization (WHO) estimates that by 2030, over 50 million people in the region will be living with cataracts, and it remains the leading cause of blindness.

In countries like India, China, and Japan, where the aging population is rapidly increasing, the demand for cataract surgeries and related ophthalmic treatments is soaring. Cataract surgery often involves the use of ophthalmic sutures for wound closure, driving the demand for sutures.

For instance, the World Bank's Implementation Completion Report provides information on the major achievements of the Cataract Blindness project in India. Based on an estimated 3.5 million cataract surgeries each year, about 320,000 people are saved from blindness annually. Overall population prevalence of cataract blindness declined by 26 percent, from 1.5 percent at baseline to 1.1 percent, during the program period. These rising cataract surgeries boost the demand for ophthalmic sutures in the region.

Competitive Landscape

The major global players in the ophthalmic sutures market include B. Braun SE, Johnson & Johnson Medical NV., Medtronic plc, DemeTECH Corporation, Corza Medical, KATSAN Katgut Industry and Trade Inc., Golnit, Accutome Inc. Aurolab, Dolphin Sutures and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Ophthalmic Sutures market report delivers a detailed analysis with 70 key tables, more than 64 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Absorption Capacity
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Eye Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Shift Towards Sutureless Surgical Techniques
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics

5. Ophthalmic Sutures Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Natural Sutures*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Synthetic Sutures

6. Ophthalmic Sutures Market, By Absorption Capacity

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 6.1.2. Market Attractiveness Index, By Absorption Capacity
  • 6.2. Absorbable Sutures*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Absorbable Sutures

7. Ophthalmic Sutures Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cataract Surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Corneal Transplantation Surgery
  • 7.4. Vitrectomy Surgery
  • 7.5. Iridectomy Surgery
  • 7.6. Oculoplastic Surgery
  • 7.7. Others

8. Ophthalmic Sutures Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ophthalmic Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. Ophthalmic Sutures Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Absorption Capacity
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. B. Braun SE*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Johnson & Johnson Medical NV.
  • 11.3. Medtronic plc
  • 11.4. DemeTECH Corporation
  • 11.5. Corza Medical
  • 11.6. KATSAN Katgut Industry and Trade Inc.
  • 11.7. Golnit
  • 11.8. Accutome Inc.
  • 11.9. Aurolab
  • 11.10. Dolphin Sutures

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us